" Efesovir " (FS-1) for COVID-19, Phase 2
Condition:   Covid19 Intervention:   Drug: Efesovir Sponsor:   Scientific Center for Anti-infectious Drugs, Kazakhstan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2021 Category: Research Source Type: clinical trials

Organ-substituting Technologies in the Treatment of Heart and Pulmonary Failure
Conditions:   Acute Respiratory Distress Syndrome;   Septic Shock;   Sepsis Interventions:   Device: Cytokine adsorber filter;   Device: Extracorporeal hemoperfusion cartridge Sponsors:   National Research Center for Cardiac Surgery, Kazakhstan;   Ministry of Education and Science, Republic of Kazakhstan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2021 Category: Research Source Type: clinical trials